Showing results (41-50 of 144) with videos related to

Sort By:
Pageof 15
BJU International|September 11, 2008
A phase II study of high-dose calcitriol combined with mitoxantrone and prednisone for androgen-independent prostate cancerJoseph S Chan, Tomasz M Beer, David I Quinn, et al.
Cancer|January 11, 2005
Phase II study of transdermal estradiol in androgen-independent prostate carcinomaLisa B Bland, Mark Garzotto, Thomas G DeLoughery, et al.
Journal of Lipid Research|November 22, 2005
Effects of transdermal estrogen on levels of lipids, lipase activity, and inflammatory markers in men with prostate cancerJonathan Q Purnell, Lisa B Bland, Mark Garzotto, et al.
The Journal of Urology|January 13, 2006
Testosterone loss and estradiol administration modify memory in menTomasz M Beer, Lisa B Bland, Joseph R Bussiere, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 2004
Phase II trial of PS-341 in patients with renal cell cancer: a University of Chicago phase II consortium studyNancy B Davis, David A Taber, Rafat H Ansari, et al.
Cancer Chemotherapy and Pharmacology|March 8, 2006
A phase II trial of O6-benzylguanine and carmustine in patients with advanced soft tissue sarcomaChristopher W Ryan, M Eileen Dolan, Bruce B Brockstein, et al.
Clinical Genitourinary Cancer|February 9, 2021
The Evolving Landscape of Antibody-Drug Conjugates for Urothelial CarcinomaMelissa Abel, Aaron Burkenroad, Alexander Sun, et al.
Investigative Ophthalmology & Visual Science|July 16, 2011
The role of Vldlr in intraretinal angiogenesis in miceChun-Hong Xia, Eric Lu, Haiquan Liu, et al.
Cancer Chemotherapy and Pharmacology|October 27, 2006
Phase I study of weekly DN-101, a new formulation of calcitriol, in patients with cancerTomasz M Beer, Milind M Javle, Christopher W Ryan, et al.
Pageof 15